Scancell Holdings PLC SCNLF
Set alert
At close · Oct 26
- YTD
- -22.53%
- 1 year
- -22.53%
- Open
- 0.141
- Prev close
- 1.41
- Mkt cap
- 1.91B
- Vol
- 15.00K
- Avg vol
- 495
- EPS
- -0.23
- P/E
- 0.00
More statistics
- Low
- 0.141
- High
- 0.141
News
3 weeks ago proactiveinvestors.com
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans to list on the Nasdaq stock exchange following an all-share merger with US…
1 month ago proactiveinvestors.com
Scancell Holdings secures $25m financing as it advances melanoma trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) told investors it has secured up to US$25 million of debt financing from funds and accounts managed by BlackRock, bolstering the funding package…
2 months ago proactiveinvestors.co.uk
Cancer vaccine breakthrough at Moderna raises hopes for Scancell's melanoma programme
A landmark trial success for Moderna and Merck's cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the immuno-oncology company developing a rival…
2 months ago proactiveinvestors.com
Marvell shares jump as Google warrant deepens AI chip partnership
Marvell Technology Inc (NASDAQ:MRVL) issued Alphabet's Google a warrant to buy up to 58.97 million shares at $206.58 apiece, expanding a custom chip...
2 months ago proactiveinvestors.co.uk
Scancell secures UK clearance for late-stage melanoma trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the cancer immunotherapy developer, has won UK regulatory approval to run a late-stage trial of its lead drug in advanced melanoma. The Medicines…
3 months ago proactiveinvestors.com
Ford and GM upgraded by Jefferies on improving outlooks, stronger cash generation
Ford Motor Company (NYSE:F) and General Motors Company (NYSE:GM) have both been upgraded to ‘Buy’ by Jefferies analysts, who pointed to improving earnings...
3 months ago proactiveinvestors.com
Chip stocks slide as China advances domestic lithography, memory production
Shares of major chipmakers fell sharply on Monday after reports that a state-backed Chinese firm has begun mass-producing domestic deep ultraviolet (DUV)...
3 months ago proactiveinvestors.co.uk
Scancell sees high demand in retail share offer, seals £15.7m from UK investors
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) confirmed the UK leg of its equity funding has raised gross proceeds of £15.7 million after strong retail demand prompted the cancer immunotherapy…
3 months ago proactiveinvestors.com
SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) saw its shares drop 27% this week, but the movement obscures the real story, which is a largely...
3 months ago proactiveinvestors.com
American Airlines shares fall as fuel costs weigh on third-quarter outlook despite earnings beat
American Airlines Group Inc (NASDAQ:AAL, XETRA:A1G) shares fell about 8% Thursday after the carrier reported better-than-expected second quarter results but...
3 months ago globenewswire.com
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
OXFORD, United Kingdom and BURLINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) (“Scancell”) and Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria”) today…
3 months ago proactiveinvestors.com
Scancell to join Nasdaq through Neuphoria merger and $89 million funding package
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the Oxford-based cancer immunotherapy developer listed on London's junior AIM market, has agreed an...
3 months ago proactiveinvestors.co.uk
Scancell to join Nasdaq through Neuphoria merger and $89 million funding package
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the Oxford-based cancer immunotherapy developer listed on London's junior AIM market, has agreed an all-share merger with US biotech Neuphoria…
4 months ago globenewswire.com
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination BURLINGTON, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or…
4 months ago proactiveinvestors.co.uk
Scancell confirms advanced talks over reverse merger with Neuphoria
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of immunotherapies designed to treat cancer, has confirmed it is in advanced discussions over a reverse merger with US-listed…
6 months ago proactiveinvestors.com
Scancell's melanoma data keeps widening the gap over standard care as phase III funding race heats up
Panmure Liberum holds its 'buy' rating and 32p target as FDA fast-track status adds regulatory momentum to compelling trial data. Scancell Holdings PLC...
6 months ago proactiveinvestors.co.uk
Scancell's melanoma data keeps widening the gap over standard care as phase III funding race heats up
Panmure Liberum holds its 'buy' rating and 32p target as FDA fast-track status adds regulatory momentum to compelling trial data. Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) shares rose 5.3%…
6 months ago proactiveinvestors.co.uk
Scancell wins FDA fast-track status for melanoma immunotherapy
The AIM-listed biotech reports 77% progression-free survival at 20 months, well ahead of the standard of care Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the cancer immunotherapy developer,…
6 months ago globenewswire.com
Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study
Potent and durable efficacy with iSCIB1+ of 77% progression free survival (PFS) at 20 months, in combination with ipilimumab and nivolumab, demonstrated in the Phase 2 SCOPE trial; more PFS and…
7 months ago proactiveinvestors.com
US banks set to deliver solid first quarter results amid macroeconomic uncertainty
Major US banks are poised to deliver solid first quarter results, though broader economic concerns may temper investor enthusiasm as earnings season begins,...
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday